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Erratum
(1) In this article published in the September 2010 issue of Neoplasia, the Figure 4 used was incorrect. Shown below is the correct figure.
1. Le Calvé B, Rynkowski M, Le Mercier M, Bruyère C, Lonez C, Gras T, Haibe-Kains B, Bontempi G, Decaestecker C, Ruysschaert J-M,
et al. (2010). Long-term in vitro treatment of human glioblastoma cells with temozolomide increases resistance in vivo through up-regulation
of GLUT transporter and aldo-keto reductase enzyme AKR1C expression. Neoplasia 12: 727–739.
Figure 4. Western blot analysis of GLUT-10 (A) and GLUT-3 (B) expression in T98G and U373 TMZ-S and TMZ-LTT GBM cells. (C) Low-
magnification (×80) immunofluorescence analysis of GLUT-10 in U373 GBM cells with TMZ-LTT (Cb) versus TMZ-S (Ca). The white arrows
point to a very intense GLUT-10–associated spot that is apparent in each U373 GBM cell. High-magnification (×400) of bright-field (Cc)
versus immunofluorescence (Cd) analyses in U373 TMZ-LTT are also provided: the blue DAPI stain reveals the nucleus of a U373 TMZ-LTT
GBM cell, whereas the green stain highlightsGLUT-10 perinuclear localization. (D) Low-magnification (×80) immunofluorescence analysis of
GLUT-3 protein expression in TMZ-LTT (Db) versus TMZ-S (Da) U373 GBM cells. The white arrows point to a very intense GLUT-3–associated
spot that is apparent in each U373 GBM cell.
